186 related articles for article (PubMed ID: 20814749)
1. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells.
Park HJ; Kim JK; Jeon HM; Oh SY; Kim SH; Nam DH; Kim H
Mol Cells; 2010 Nov; 30(5):403-8. PubMed ID: 20814749
[TBL] [Abstract][Full Text] [Related]
2. The nuclear receptor TLX is required for gliomagenesis within the adult neurogenic niche.
Zou Y; Niu W; Qin S; Downes M; Burns DK; Zhang CL
Mol Cell Biol; 2012 Dec; 32(23):4811-20. PubMed ID: 23028043
[TBL] [Abstract][Full Text] [Related]
3. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
4. The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation.
Liu HK; Wang Y; Belz T; Bock D; Takacs A; Radlwimmer B; Barbus S; Reifenberger G; Lichter P; Schütz G
Genes Dev; 2010 Apr; 24(7):683-95. PubMed ID: 20360385
[TBL] [Abstract][Full Text] [Related]
5. Monitoring in real time the effect of TLX overexpression on proliferation and migration of C6 cells.
Li GL; Fang SH; Xu B
Neoplasma; 2017; 64(1):48-55. PubMed ID: 27881004
[TBL] [Abstract][Full Text] [Related]
6. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
7. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
Zhou J; Pei X; Yang Y; Wang Z; Gao W; Ye R; Zhang X; Liu J; Liu Z; Yang X; Tao J; Gu C; Hu W; Chan FL; Li X; Mao J; Wu D
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858847
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells.
Wang L; Liu Z; Balivada S; Shrestha T; Bossmann S; Pyle M; Pappan L; Shi J; Troyer D
Stem Cell Res Ther; 2012 Feb; 3(1):5. PubMed ID: 22330721
[TBL] [Abstract][Full Text] [Related]
9. Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras.
Lee JS; Gil JE; Kim JH; Kim TK; Jin X; Oh SY; Sohn YW; Jeon HM; Park HJ; Park JW; Shin YJ; Chung YG; Lee JB; You S; Kim H
Biochem Biophys Res Commun; 2008 Jan; 365(3):496-502. PubMed ID: 18021740
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-146a inhibits glioma development by targeting Notch1.
Mei J; Bachoo R; Zhang CL
Mol Cell Biol; 2011 Sep; 31(17):3584-92. PubMed ID: 21730286
[TBL] [Abstract][Full Text] [Related]
11. Bmi-1 over-expression in neural stem/progenitor cells increases proliferation and neurogenesis in culture but has little effect on these functions in vivo.
He S; Iwashita T; Buchstaller J; Molofsky AV; Thomas D; Morrison SJ
Dev Biol; 2009 Apr; 328(2):257-72. PubMed ID: 19389366
[TBL] [Abstract][Full Text] [Related]
12. MEF promotes stemness in the pathogenesis of gliomas.
Bazzoli E; Pulvirenti T; Oberstadt MC; Perna F; Wee B; Schultz N; Huse JT; Fomchenko EI; Voza F; Tabar V; Brennan CW; DeAngelis LM; Nimer SD; Holland EC; Squatrito M
Cell Stem Cell; 2012 Dec; 11(6):836-44. PubMed ID: 23217424
[TBL] [Abstract][Full Text] [Related]
13. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
14. Stem cells in brain tumorigenesis and their impact on therapy.
Cardona AF; Balañá C; Torres D; Becerra H; Ortíz LD; Fadul CE
Curr Stem Cell Res Ther; 2011 Dec; 6(4):339-49. PubMed ID: 21466481
[TBL] [Abstract][Full Text] [Related]
15. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
[TBL] [Abstract][Full Text] [Related]
16. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
17. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
18. TLX-Its Emerging Role for Neurogenesis in Health and Disease.
Sobhan PK; Funa K
Mol Neurobiol; 2017 Jan; 54(1):272-280. PubMed ID: 26738856
[TBL] [Abstract][Full Text] [Related]
19. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
[TBL] [Abstract][Full Text] [Related]
20. EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell.
Chen P; Rossi N; Priddy S; Pierson CR; Studebaker AW; Johnson RA
Sci Rep; 2015 Mar; 5():9248. PubMed ID: 25801123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
